article thumbnail

Trust in Healthcare is Under Stress in the US and Globally, Edelman Finds

Health Populi

Fast-forward to January 2021, and Edelman’s survey learned that health consumers around the world lost trust in their health care systems from May 2020 to January in the new year. The one segment which has stayed relatively even from 2018 has been biotech, 55% that year and 55% again in 2021. On these factors, the U.S.

BioTech 317
article thumbnail

Tools for Paying Medical Bills Don’t Help Health Consumers Manage Their Financial Health

Health Populi

The key findings in the survey of 136 health care executives were that: Digital health tools are a priority for half of the health system leaders. Only 1 in 3 felt their consumer digital experience was considered “the best possible”. Even trust with pharmaceutical companies increased that year.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Americans’ Trust in U.S. Healthcare Lags Tech — and Women Are Particularly Cynical

Health Populi

This week, Edelman released more granular healthcare insights from the annual omnibus survey that was published during the World Economic Forum in Davos in January. In this study, the healthcare industry is comprised of five segments: hospitals and clinics; pharma; biotech (separate from pharma); consumer health (e.g.,

BioTech 208
article thumbnail

Employee Benefits are Evolving with Help from AI

Healthcare IT Today

Biotech and software firms are actively investing in AI healthcare platforms capable of symptom assessment, multilingual medical guidance, and automated notetaking. Nearly 69% of employers now offer personalized health and wellness programs , according to a RAND Employer Survey. billion by 2033.

BioTech 130
article thumbnail

In U.S. Health Care, It’s Still the Prices, Stupid – But Transparency and Consumer Behavior Aren’t Working As Planned

Health Populi

First, a Wall Street Journal profile of Bluebird Bio , a biotech firm that plans to sell gene-replacement therapy extending annual payments to patients based on whether the drug is effective. As the Harvard Chan-POLITICO study points out, prescription drug costs are top-of-mind for health consumers in America.

BioTech 166
article thumbnail

Pharma’s Future Relevance Depends on Empathy, Messaging, Partnering, and Supporting Patients and Providers

Health Populi

For the study, Accenture surveyed 720 health care providers in general practice, oncology, immunology, and cardiology working in China, France, Japan, the United Kingdom, and the U.S., in May and June 2020.

article thumbnail

Let’s Save the Date and Make Patient Engagement Official in 2022

Society for Participatory Medicine

Patient engagement is measured by Consumer Assessment of Healthcare Processes and Services (CAHPS) surveys & Patient Activation Measures (PAM). Healthcare stakeholders such as health systems, pharmaceutical companies, biotech and life sciences firms, and insurance companies serve patients as end users.

BioTech 97